Deutsche Bank AG Buys Shares of 397,190 Zymeworks Inc. $ZYMEMarket Beat·1 day ago, 02:52 AMZYME+0.35%DB+1.59%
How Zymeworks’ Bigger Loss, Buyback and Milestones Pivot At Zymeworks (ZYME) Has Changed Its Investment StorySimplywall·Aug 17 at 10:48 PMZYME+0.35%
Zymeworks (ZYME) Back In Focus After Q2 Loss, Buyback, And Pipeline Events Raised Valuation QuestionsSimplywall·Aug 16 at 02:41 PMZYME+0.35%
TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its ShareholdersMorningStar·Aug 15 at 06:24 AMTBPH0.00%ZYME+0.35%
Zymeworks management attends Wells Fargo Healthcare Conference fireside chatPUBT·Aug 11 at 05:00 AMZYME+0.35%C+0.05%
TBPH: Definitive acquisition agreement, strong YUPELRI® growth, and major cost reductions in Q2 2026Quartr·Aug 10 at 07:49 AMTBPH0.00%ZYME+0.35%
Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update | TBPH Stock NewsStockTitan·Aug 9 at 11:30 PMTBPH0.00%ZYME+0.35%
Zymeworks (NASDAQ:ZYME) Issues Earnings Results, Misses Expectations By $0.05 EPSMarket Beat·Aug 7 at 04:41 PMZYME+0.35%
Zymeworks revenue drops 90.57% to $4.6 million in FY26 Q2; net loss widens to $45 millionPUBT·Aug 6 at 03:22 PMTBPH0.00%ZYME+0.35%
Perceptive Advisors LLC Increases Stock Holdings in Zymeworks Inc. $ZYMEMarket Beat·Aug 2 at 05:16 AMZYME+0.35%
Beyond the Big Tech Platform Wars: The Fringe Economy from AI Cooling to Nuclear FusionGlobal Report·Jul 22 at 04:18 AMZYME+0.35%TT-0.10%
